Counsel Stack
|
Law
Browse
Pricing
Counsel Stack
API Docs
Home
/
U.S. Code
/
Title 21
FEDERAL · U.S. CODE
Title 21 — Food and Drugs
710 sections across 23 chapters.
View on OLRC ↗
#1 Ranked Citator API
Verify citations & detect hallucinations across 29M+ references to primary authority.
Learn more
·
API docs
Chapter 1
ADULTERATED OR MISBRANDED FOODS OR DRUGS
§ 6
Transferred
§ 14a
Transferred
§ 15
Repealed. June 25, 1938, ch. 675, §1002(a), formerly §902(a), 52 Stat. 1059; renumbered §1002(a), Pub. L. 111–31, div. A, title I, §101(b)(2), June 22, 2009, 123 Stat. 1784
§ 16
Introduction into, or sale in, State or Territory or District of Columbia of dairy or food products falsely labeled or branded
§ 17
Penalty for sale or introduction of falsely labeled dairy or food products; venue
§ 18
Suspension of importation of adulterated articles
§ 19
Repealed. May 29, 1928, ch. 901, §1(100), 45 Stat. 993
§ 20
Apples in interstate commerce; standard grades
§ 21
Branding grades on barrels of apples
§ 22
Barrels misbranded
§ 23
Penalties
§ 24
Omitted
§ 25
Oleomargarine, butterine, or imitation butter or cheese transported into a State subject to its police powers
§ 26
Omitted
Chapter 3
FILLED MILK
§ 61
Definitions
§ 62
Manufacture, shipment, or delivery for shipment in interstate or foreign commerce prohibited
§ 63
Penalties; acts of agents deemed acts of principals
§ 64
Regulations for enforcement
Chapter 4
ANIMALS, MEATS, AND MEAT AND DAIRY PRODUCTS
§ 93
Repealed. May 29, 1928, ch. 901, §1(92), 45 Stat. 993
§ 96
Repealed. Pub. L. 90–201, §18, Dec. 15, 1967, 81 Stat. 600
§ 98
Transferred
§ 99
Repealed. July 28, 1953, ch. 251, title I, §101, 67 Stat. 208
§ 101
Suspension of importation of all animals
§ 112a
Omitted
§ 113
Repealed. Pub. L. 107–171, title X, §10418(a)(7), (8), May 13, 2002, 116 Stat. 507, 508
§ 113a
Establishment of research laboratories for foot-and-mouth disease and other animal diseases; research contracts; employment of technicians and scientists; appropriations
§ 114i
Pseudorabies eradication
§ 129
Omitted
§ 132
Transferred
§ 133
Repealed. July 13, 1949, ch. 307, 63 Stat. 410
§ 136
Additional inspection services
§ 136a
Collection of fees for inspection services
§ 141
Prohibition of importation without permit
§ 142
Milk or cream when unfit for importation
§ 143
Inspection; certified statement in lieu thereof; waiver of requirements of section 142; regulations; suspension and revocation of permits
§ 144
Unlawful receiving of imported milk or cream
§ 145
Penalties
§ 146
Authorization of appropriations
§ 147
Repeal of inconsistent laws
§ 148
Powers of State with respect to milk or cream lawfully imported
§ 149
Definitions
Chapter 5
VIRUSES, SERUMS, TOXINS, ANTITOXINS, AND ANALOGOUS PRODUCTS
§ 151
Preparation and sale of worthless or harmful products for domestic animals prohibited; preparation to be in compliance with rules at licensed establishments
§ 152
Importation regulated and prohibited
§ 153
Inspection of imports; denial of entry and destruction
§ 154
Regulations for preparation and sale; licenses
§ 154a
Special licenses for special circumstances; expedited procedure; conditions; exemptions; criteria
§ 155
Permits for importation
§ 156
Licenses conditioned on permitting inspection; suspension of licenses
§ 157
Inspection
§ 158
Offenses; punishment
§ 159
Enforcement; penalties applicable; Congressional findings
Chapter 6
NARCOTIC DRUGS
§ 175
Repealed. June 27, 1952, ch. 477, title IV, §403(a)(10), 66 Stat. 279
§ 196
Repealed. July 1, 1944, ch. 373, title XIII, §1313, 58 Stat. 714
§ 199
Repealed. Pub. L. 91–513, title III, §1101(a)(5), Oct. 27, 1970, 84 Stat. 1292
Chapter 7
PRACTICE OF PHARMACY AND SALE OF POISONS IN CONSULAR DISTRICTS IN CHINA
§ 201
Doing business without a license unlawful; employment of Chinese subjects
§ 202
Certain classes of persons and corporations excepted; insecticides
§ 203
Application for license; requirements; qualifications for license
§ 204
Issuance of license
§ 205
Display of license in pharmacy
§ 206
Revocation of license
§ 207
Restrictions on sales; written orders or prescriptions
§ 208
Certain preparations and sales excepted
§ 209
Poisons; book entry of sale; labels
§ 210
Pharmacist; unauthorized use of title
§ 211
Preservation of originals of prescriptions compounded and copies thereof; inspection of prescriptions by consular officers; marking containers of drugs
§ 212
Offenses; punishment; duty to enforce provisions
§ 213
Fraudulent representations to evade or defeat restrictions
§ 214
Previous laws unaffected
§ 215
"Consul" defined
Chapter 9
FEDERAL FOOD, DRUG, AND COSMETIC ACT
§ 301
Short title
§ 321
Definitions; generally
§ 321a
"Butter" defined
§ 321b
"Package" defined
§ 321c
Nonfat dry milk; "milk" defined
§ 321d
Market names for catfish and ginseng
§ 331
Prohibited acts
§ 332
Injunction proceedings
§ 333
Penalties
§ 333a
Repealed. Pub. L. 101–647, title XIX, §1905, Nov. 29, 1990, 104 Stat. 4853
§ 334
Seizure
§ 335
Hearing before report of criminal violation
§ 335a
Debarment, temporary denial of approval, and suspension
§ 335b
Civil penalties
§ 335c
Authority to withdraw approval of abbreviated drug applications
§ 336
Report of minor violations
§ 337
Proceedings in name of United States; provision as to subpoenas
§ 337a
Extraterritorial jurisdiction
§ 341
Definitions and standards for food
§ 342
Adulterated food
§ 343
Misbranded food
§ 343a
Repealed. Pub. L. 106–554, §1(a)(1) [title V, §517], Dec. 21, 2000, 114 Stat. 2763, 2763A–73
§ 344
Emergency permit control
§ 345
Regulations making exemptions
§ 346
Tolerances for poisonous or deleterious substances in food; regulations
§ 346a
Tolerances and exemptions for pesticide chemical residues
§ 346b
Authorization of appropriations
§ 347
Intrastate sales of colored oleomargarine
§ 347a
Congressional declaration of policy regarding oleomargarine sales
§ 347b
Contravention of State laws
§ 348
Food additives
§ 349
Bottled drinking water standards; publication in Federal Register
§ 350
Vitamins and minerals
§ 350a
Infant formulas
§ 350b
New dietary ingredients
§ 350c
Maintenance and inspection of records
§ 350d
Registration of food facilities
§ 350e
Sanitary transportation practices
§ 350f
Reportable food registry
§ 350g
Hazard analysis and risk-based preventive controls
§ 350h
Standards for produce safety
§ 350i
Protection against intentional adulteration
§ 350j
Targeting of inspection resources for domestic facilities, foreign facilities, and ports of entry; annual report
§ 350k
Laboratory accreditation for analyses of foods
§ 350l
Mandatory recall authority
§ 350m
Requirements for critical food
§ 351
Adulterated drugs and devices
§ 352
Misbranded drugs and devices
§ 353
Exemptions and consideration for certain drugs, devices, and biological products
§ 353a
Pharmacy compounding
§ 353b
Outsourcing facilities
§ 353c
Prereview of television advertisements
§ 353d
Process to update labeling for certain generic drugs
§ 354
Veterinary feed directive drugs
§ 355
New drugs
§ 355a
Pediatric studies of drugs
§ 355b
Adverse-event reporting
§ 355c
Research into pediatric uses for drugs and biological products
§ 355d
Internal committee for review of pediatric plans, assessments, deferrals, deferral extensions, and waivers
§ 355e
Pharmaceutical security
§ 355f
Extension of exclusivity period for new qualified infectious disease products
§ 355g
Utilizing real world evidence
§ 355h
Regulation of certain nonprescription drugs that are marketed without an approved drug application
§ 356
Expedited approval of drugs for serious or life-threatening diseases or conditions
§ 356a
Manufacturing changes
§ 356b
Reports of postmarketing studies
§ 356c
Discontinuance or interruption in the production of life-saving drugs
§ 356d
Coordination; task force and strategic plan
§ 356e
Drug shortage list
§ 356f
Hospital repackaging of drugs in shortage
§ 356g
Standards for regenerative medicine and regenerative advanced therapies
§ 356h
Competitive generic therapies
§ 356i
Prompt reports of marketing status
§ 356j
Discontinuance or interruption in the production of medical devices
§ 356k
Platform technologies
§ 356l
Advanced manufacturing technologies designation program
§ 357
Qualification of drug development tools
§ 358
Authority to designate official names
§ 359
Nonapplicability of subchapter to cosmetics
§ 360
Registration of producers of drugs or devices
§ 360a
Clinical trial guidance for antibiotic drugs
§ 360aa
Recommendations for investigations of drugs for rare diseases or conditions
§ 360b
New animal drugs
§ 360bb
Designation of drugs for rare diseases or conditions
§ 360bbb
Expanded access to unapproved therapies and diagnostics
§ 360c
Classification of devices intended for human use
§ 360cc
Protection for drugs for rare diseases or conditions
§ 360ccc
Conditional approval of new animal drugs for minor use and minor species and certain new animal drugs
§ 360d
Performance standards
§ 360dd
Open protocols for investigations of drugs for rare diseases or conditions
§ 360ddd
Definitions
§ 360e
Premarket approval
§ 360ee
Grants and contracts for development of drugs for rare diseases and conditions
§ 360eee
Definitions
§ 360f
Banned devices
§ 360ff
Priority review to encourage treatments for rare pediatric diseases
§ 360fff
Definitions
§ 360g
Judicial review
§ 360h
Notification and other remedies
§ 360hh
Definitions
§ 360i
Records and reports on devices
§ 360ii
Program of control
§ 360j
General provisions respecting control of devices intended for human use
§ 360jj
Studies by Secretary
§ 360k
State and local requirements respecting devices
§ 360kk
Performance standards for electronic products
§ 360l
Postmarket surveillance
§ 360ll
Notification of defects in and repair or replacement of electronic products
§ 360m
Accredited persons
§ 360mm
Imports
§ 360n
Priority review to encourage treatments for tropical diseases
§ 360nn
Inspection, records, and reports
§ 360oo
Prohibited acts
§ 360pp
Enforcement
§ 360qq
Repealed. Pub. L. 105–362, title VI, §601(a)(2)(A), Nov. 10, 1998, 112 Stat. 3285
§ 360rr
Federal-State cooperation
§ 360ss
State standards
§ 361
Adulterated cosmetics
§ 362
Misbranded cosmetics
§ 363
Regulations making exemptions
§ 364
Definitions
§ 364a
Adverse events
§ 364b
Good manufacturing practice
§ 364c
Registration and product listing
§ 364d
Safety substantiation
§ 364e
Labeling
§ 364f
Records
§ 364g
Mandatory recall authority
§ 364h
Small businesses
§ 364i
Exemption for certain products and facilities
§ 364j
Preemption
§ 371
Regulations and hearings
§ 372
Examinations and investigations
§ 372a
Transferred
§ 373
Records
§ 374
Inspection
§ 374a
Inspections relating to food allergens
§ 375
Publicity
§ 376
Examination of sea food on request of packer; marking food with results; fees; penalties
§ 377
Revision of United States Pharmacopoeia; development of analysis and mechanical and physical tests
§ 378
Advertising of foods
§ 379
Confidential information
§ 379a
Presumption of existence of jurisdiction
§ 379aa
Serious adverse event reporting for nonprescription drugs
§ 379b
Consolidated administrative and laboratory facility
§ 379c
Transferred
§ 379d
Automation of Food and Drug Administration
§ 379dd
Establishment and functions of the Foundation
§ 379e
Listing and certification of color additives for foods, drugs, devices, and cosmetics
§ 379f
Recovery and retention of fees for freedom of information requests
§ 379g
Definitions
§ 379h
Authority to assess and use drug fees
§ 379i
Definitions
§ 379j
Authority to assess and use device fees
§ 379k
Information system
§ 379l
Education
§ 379o
Environmental impact
§ 379r
National uniformity for nonprescription drugs
§ 379s
Preemption for labeling or packaging of cosmetics
§ 379v
Safety report disclaimers
§ 381
Imports and exports
§ 382
Exports of certain unapproved products
§ 383
Office of International Relations
§ 384
Importation of prescription drugs
§ 384a
Foreign supplier verification program
§ 384b
Voluntary qualified importer program
§ 384c
Inspection of foreign food facilities
§ 384d
Accreditation of third-party auditors
§ 384e
Recognition of foreign government inspections
§ 384f
Strengthening FDA and CBP coordination and capacity
§ 384g
Restricting entrance of illicit drugs
§ 387
Definitions
§ 387a
FDA authority over tobacco products
§ 387b
Adulterated tobacco products
§ 387c
Misbranded tobacco products
§ 387d
Submission of health information to the Secretary
§ 387e
Annual registration
§ 387f
General provisions respecting control of tobacco products
§ 387g
Tobacco product standards
§ 387h
Notification and other remedies
§ 387i
Records and reports on tobacco products
§ 387j
Application for review of certain tobacco products
§ 387k
Modified risk tobacco products
§ 387l
Judicial review
§ 387m
Equal treatment of retail outlets
§ 387n
Jurisdiction of and coordination with the Federal Trade Commission
§ 387o
Regulation requirement
§ 387p
Preservation of State and local authority
§ 387q
Tobacco Products Scientific Advisory Committee
§ 387r
Drug products used to treat tobacco dependence
§ 387s
User fees
§ 387t
Labeling, recordkeeping, records inspection
§ 387u
Studies of progress and effectiveness
§ 387v
Reporting on tobacco regulation activities
§ 391
Separability clause
§ 392
Exemption of meats and meat food products
§ 393
Food and Drug Administration
§ 393a
Office of Pediatric Therapeutics
§ 394
Scientific review groups
§ 395
Loan repayment program
§ 396
Practice of medicine
§ 397
Contracts for expert review
§ 398
Notices to States regarding imported food
§ 399
Grants to enhance food safety
§ 399a
Office of the Chief Scientist
§ 399b
Office of Women's Health
§ 399c
Improving the training of State, local, territorial, and tribal food safety officials
§ 399d
Employee protections
§ 399e
Nanotechnology
§ 399f
Ensuring adequate information regarding pharmaceuticals for all populations, particularly underrepresented subpopulations, including racial subgroups
§ 399g
Food and Drug Administration Intercenter Institutes
§ 399h
National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing
§ 399i
Food and Drug Administration Working Capital Fund
§ 399j
Abraham Accords Office
§ 343–1
National uniform nutrition labeling
§ 343–2
Dietary supplement labeling exemptions
§ 343–3
Disclosure
§ 350a–1
Protecting infants and improving formula supply
§ 350l–1
Annual report to Congress
§ 353a–1
Enhanced communication
§ 355c–1
Report
§ 355–1
Risk evaluation and mitigation strategies
§ 355–2
Actions for delays of generic drugs and biosimilar biological products
§ 356c–1
Annual reporting on drug shortages
§ 356–1
Accelerated approval of priority countermeasures
§ 356–2
Accelerated approval Council
§ 360bbb–0
Expanded access policy required for investigational drugs
§ 360bbb–0a
Investigational drugs for use by eligible patients
§ 360a–1
Clinical trials
§ 360bbb–1
Dispute resolution
§ 360b–1
Priority zoonotic animal drugs
§ 360ccc–1
Index of legally marketed unapproved new animal drugs for minor species
§ 360c–1
Reporting
§ 360ddd–1
Regulation of medical gases
§ 360eee–1
Requirements
§ 360ee–1
FDA rare neurodegenerative disease grant program
§ 360e–1
Pediatric uses of devices
§ 360fff–1
Submission of requests
§ 360ff–1
Targeted drugs for rare diseases
§ 360g–1
Agency documentation and review of significant decisions regarding devices
§ 360h–1
Program to improve the device recall system
§ 360n–1
Priority review for qualified infectious disease products
§ 360a–2
Susceptibility test interpretive criteria for microorganisms
§ 360bbb–2
Classification of products
§ 360ccc–2
Designated new animal drugs for minor use or minor species
§ 360ddd–2
Inapplicability of drug fees to designated medical gases
§ 360eee–2
National standards for prescription drug wholesale distributors
§ 360fff–2
Eligibility determinations; data submission; filing
§ 360g–2
Third party data transparency
§ 360n–2
Ensuring cybersecurity of devices
§ 360bbb–3
Authorization for medical products for use in emergencies
§ 360bbb–3a
Emergency use of medical products
§ 360bbb–3b
Products held for emergency use
§ 360bbb–3c
Expedited development and review of medical products for emergency uses
§ 360eee–3
National standards for third-party logistics providers
§ 360e–3
Breakthrough devices
§ 360fff–3
GRASE determination
§ 360bbb–4
Countermeasure development, review, and technical assistance
§ 360bbb–4a
Priority review to encourage treatments for agents that present national security threats
§ 360bbb–4b
Medical countermeasure master files
§ 360eee–4
Uniform national policy
§ 360e–4
Predetermined change control plans for devices
§ 360fff–4
Guidance; other provisions
§ 360bbb–5
Critical Path Public-Private Partnerships
§ 360bbb–5a
Emerging technology program
§ 360fff–5
Repealed. Pub. L. 116–136, div. A, title III, §3854(b)(5), Mar. 27, 2020, 134 Stat. 456
§ 360bbb–6
Risk communication
§ 360fff–6
Non-sunscreen time and extent applications
§ 360bbb–7
Notification
§ 360fff–7
Report
§ 360bbb–8
Consultation with external experts on rare diseases, targeted therapies, and genetic targeting of treatments
§ 360bbb–8a
Optimizing global clinical trials
§ 360bbb–8b
Use of clinical investigation data from outside the United States
§ 360bbb–8c
Patient participation in medical product discussion
§ 360bbb–8d
Notification, nondistribution, and recall of controlled substances
§ 360fff–8
Sunset
§ 379aa–1
Serious adverse event reporting for dietary supplements
§ 379dd–1
Location of Foundation
§ 379d–1
Conflicts of interest
§ 379h–1
Fees relating to advisory review of prescription-drug television advertising
§ 379j–1
Reauthorization; reporting requirements
§ 379k–1
Electronic format for submissions
§ 379dd–2
Activities of the Food and Drug Administration
§ 379d–2
Policy on the review and clearance of scientific articles published by FDA employees
§ 379h–2
Reauthorization; reporting requirements
§ 379d–3
Streamlined hiring authority
§ 379d–3a
Hiring authority for scientific, technical, and professional personnel
§ 379d–3b
Strategic Workforce Plan and report
§ 379d–4
Reporting requirements
§ 379d–5
Guidance document regarding product promotion using the Internet
§ 387a–1
Final rule
§ 387f–1
Enforcement action plan for advertising and promotion restrictions
§ 379j–11
Definitions
§ 379j–12
Authority to assess and use animal drug fees
§ 379j–13
Reauthorization; reporting requirements
§ 379j–21
Authority to assess and use generic new animal drug fees
§ 379j–22
Reauthorization; reporting requirements
§ 379j–31
Authority to collect and use fees
§ 379j–41
Definitions
§ 379j–42
Authority to assess and use human generic drug fees
§ 379j–43
Reauthorization; reporting requirements
§ 379j–51
Definitions
§ 379j–52
Authority to assess and use biosimilar biological product fees
§ 379j–53
Reauthorization; reporting requirements
§ 379j–61
Definitions
§ 379j–62
Authority to assess and use outsourcing facility fees
§ 379j–71
Definitions
§ 379j–72
Authority to assess and use OTC monograph fees
§ 379j–73
Reauthorization; reporting requirements
Chapter 10
POULTRY AND POULTRY PRODUCTS INSPECTION
§ 451
Congressional statement of findings
§ 452
Congressional declaration of policy
§ 453
Definitions
§ 454
Federal and State cooperation in development and administration of State poultry product inspection programs
§ 455
Inspection in official establishments
§ 456
Operation of premises, facilities and equipment
§ 457
Labeling and container standards
§ 458
Prohibited acts
§ 459
Compliance by all establishments
§ 460
Miscellaneous activities subject to regulation
§ 461
Offenses and punishment
§ 462
Reporting of violations; notice; opportunity to present views
§ 463
Rules and regulations
§ 464
Exemptions
§ 465
Limitations upon entry of poultry products and other materials into official establishments
§ 466
Imports
§ 467
Inspection services
§ 467a
Administrative detention; duration; pending judicial proceedings; notification of government authorities; release; removal of official marks
§ 467b
Seizure and condemnation
§ 467c
Federal court jurisdiction of enforcement and injunction proceedings and other kinds of cases; limitations; United States as plaintiff; subpenas
§ 467d
Administration and enforcement; applicability of penalty provisions; conduct of inquiries; power and jurisdiction of courts
§ 467e
Non-Federal jurisdiction of federally regulated matters; prohibition of additional or different requirements for establishments with inspection services and as to marking, labeling, packaging, and ingredients; recordkeeping and related requirements; concurrent jurisdiction over distribution for human food purposes of adulterated or misbranded and imported articles; other matters
§ 467f
Federal Food, Drug, and Cosmetic Act applications
§ 468
Cost of inspection; overtime
§ 469
Authorization of appropriations
§ 470
Omitted
§ 471
Safe Meat and Poultry Inspection Panel
§ 472
Interstate shipment of poultry inspected by Federal and State agencies for certain small establishments
§ 473
Grants for improvements to meat and poultry facilities to allow for interstate shipment
Chapter 12
MEAT INSPECTION
§ 601
Definitions
§ 602
Congressional statement of findings
§ 603
Examination of animals prior to slaughter; use of humane methods
§ 604
Post mortem examination of carcasses and marking or labeling; destruction of carcasses condemned; reinspection
§ 605
Examination of carcasses brought into slaughtering or packing establishments, and of meat food products issued from and returned thereto; conditions for entry
§ 606
Inspection and labeling of meat food products
§ 607
Labeling, marking, and container requirements
§ 608
Sanitary inspection and regulation of slaughtering and packing establishments; rejection of adulterated meat or meat food products
§ 609
Examination of animals and food products thereof, slaughtered and prepared during nighttime
§ 610
Prohibited acts
§ 611
Devices, marks, labels, and certificates; simulations
§ 612
Notification
§ 613
Plans and reassessments
§ 614
Repealed. Pub. L. 107–171, title X, §10418(a)(19), May 13, 2002, 116 Stat. 508
§ 615
Inspection of carcasses, meat of which is intended for export
§ 616
Inspectors of carcasses, etc., meat of which is intended for export; certificates of condition
§ 617
Clearance prohibited to vessel carrying meat for export without inspector's certificate
§ 618
Delivery of inspectors' certificates, and of copies
§ 619
Marking, labeling, or other identification to show kinds of animals from which derived; separate establishments for preparation and slaughtering activities
§ 620
Imports
§ 621
Inspectors to make examinations provided for; appointment; duties; regulations
§ 622
Bribery of or gifts to inspectors or other officers and acceptance of gifts
§ 623
Exemptions from inspection requirements
§ 624
Storage and handling regulations; violations; exemption of establishments subject to non-Federal jurisdiction
§ 625
Inapplicability of certain requirements to catfish
§ 626
Purchase of tags, labels, stamps, and certificates
§ 641
Prohibition of subchapter I inspection of articles not intended for use as human food; denaturation or other identification prior to distribution in commerce; inedible articles
§ 642
Recordkeeping requirements
§ 643
Registration of business, name of person, and trade names
§ 644
Regulation of transactions, transportation, or importation of 4–D animals to prevent use as human food
§ 645
Federal provisions applicable to State or Territorial business transactions of a local nature and not subject to local authority
§ 661
Federal and State cooperation
§ 671
Inspection services; refusal or withdrawal; hearing; business unfitness based upon certain convictions; other provisions for withdrawal of services unaffected; responsible connection with business; finality of Secretary's actions; judicial review; record
§ 672
Administrative detention; duration; pending judicial proceedings; notification of governmental authorities; release
§ 673
Seizure and condemnation
§ 674
Federal court jurisdiction of enforcement and injunction proceedings and other kinds of cases; limitations of section 607(e) of this title
§ 675
Assaulting, resisting, or impeding certain persons; murder; protection of such persons
§ 676
Violations
§ 677
Other Federal laws applicable for administration and enforcement of chapter; location of inquiries; jurisdiction of Federal courts
§ 678
Non-Federal jurisdiction of federally regulated matters; prohibition of additional or different requirements for establishments with inspection services and as to marking, labeling, packaging, and ingredients; recordkeeping and related requirements; concurrent jurisdiction over distribution for human food purposes of adulterated or misbranded and imported articles; other matters
§ 679
Application of Federal Food, Drug, and Cosmetic Act
§ 679a
Safe Meat and Poultry Inspection Panel
§ 679b
Pasteurization of meat and poultry
§ 679c
Expansion of Food Safety Inspection Service activities
§ 680
Authorization of appropriations
§ 683
Interstate shipment of meat inspected by Federal and State agencies for certain small establishments
§ 691
Omitted
§ 692
Inspection extended to reindeer
§ 693
Inspection of dairy products for export
§ 694
Authorization of appropriations
§ 695
Payment of cost of meat-inspection service; exception
Chapter 13
DRUG ABUSE PREVENTION AND CONTROL
§ 801
Congressional findings and declarations: controlled substances
§ 801a
Congressional findings and declarations: psychotropic substances
§ 802
Definitions
§ 803
Repealed. Pub. L. 95–137, §1(b), Oct. 18, 1977, 91 Stat. 1169
§ 811
Authority and criteria for classification of substances
§ 812
Schedules of controlled substances
§ 813
Treatment of controlled substance analogues
§ 814
Removal of exemption of certain drugs
§ 821
Rules and regulations
§ 822
Persons required to register
§ 822a
Prescription drug take back expansion
§ 823
Registration requirements
§ 824
Denial, revocation, or suspension of registration
§ 825
Labeling and packaging
§ 826
Production quotas for controlled substances
§ 826a
Attorney General report on drug shortages
§ 827
Records and reports of registrants
§ 828
Order forms
§ 829
Prescriptions
§ 829a
Delivery of a controlled substance by a pharmacy to an administering practitioner
§ 830
Regulation of listed chemicals and certain machines
§ 831
Additional requirements relating to online pharmacies and telemedicine
§ 832
Suspicious orders
§ 841
Prohibited acts A
§ 842
Prohibited acts B
§ 843
Prohibited acts C
§ 844
Penalties for simple possession
§ 844a
Civil penalty for possession of small amounts of certain controlled substances
§ 846
Attempt and conspiracy
§ 847
Additional penalties
§ 848
Continuing criminal enterprise
§ 849
Transportation safety offenses
§ 850
Information for sentencing
§ 851
Proceedings to establish prior convictions
§ 852
Application of treaties and other international agreements
§ 853
Criminal forfeitures
§ 853a
Transferred
§ 854
Investment of illicit drug profits
§ 855
Alternative fine
§ 856
Maintaining drug-involved premises
§ 857
Repealed. Pub. L. 101–647, title XXIV, §2401(d), Nov. 29, 1990, 104 Stat. 4859
§ 858
Endangering human life while illegally manufacturing controlled substance
§ 859
Distribution to persons under age twenty-one
§ 860
Distribution or manufacturing in or near schools and colleges
§ 860a
Consecutive sentence for manufacturing or distributing, or possessing with intent to manufacture or distribute, methamphetamine on premises where children are present or reside
§ 861
Employment or use of persons under 18 years of age in drug operations
§ 862
Denial of Federal benefits to drug traffickers and possessors
§ 862a
Denial of assistance and benefits for certain drug-related convictions
§ 862b
Sanctioning for testing positive for controlled substances
§ 863
Drug paraphernalia
§ 864
Anhydrous ammonia
§ 864a
Grants to reduce production of methamphetamines from anhydrous ammonia
§ 865
Smuggling methamphetamine or methamphetamine precursor chemicals into the United States while using facilitated entry programs
§ 871
Attorney General
§ 871a
Semiannual reports to Congress
§ 872
Education and research programs of Attorney General
§ 872a
Public-private education program
§ 873
Cooperative arrangements
§ 874
Advisory committees
§ 875
Administrative hearings
§ 876
Subpenas
§ 877
Judicial review
§ 878
Powers of enforcement personnel
§ 879
Search warrants
§ 880
Administrative inspections and warrants
§ 881
Forfeitures
§ 882
Injunctions
§ 883
Enforcement proceedings
§ 884
Immunity and privilege
§ 885
Burden of proof; liabilities
§ 886
Payments and advances
§ 886a
Diversion Control Fee Account
§ 887
Coordination and consolidation of post-seizure administration
§ 888
Repealed. Pub. L. 106–185, §2(c)(3), Apr. 25, 2000, 114 Stat. 210
§ 889
Production control of controlled substances
§ 890
Review of Federal sales of chemicals usable to manufacture controlled substances
§ 901
Severability
§ 902
Savings provisions
§ 903
Application of State law
§ 904
Payment of tort claims
§ 951
Definitions
§ 952
Importation of controlled substances
§ 953
Exportation of controlled substances
§ 954
Transshipment and in-transit shipment of controlled substances
§ 955
Possession on board vessels, etc., arriving in or departing from United States
§ 956
Exemption authority
§ 957
Persons required to register
§ 958
Registration requirements
§ 959
Possession, manufacture, or distribution of controlled substance
§ 960
Prohibited acts A
§ 960a
Foreign terrorist organizations, terrorist persons and groups
§ 961
Prohibited acts B
§ 962
Second or subsequent offenses
§ 963
Attempt and conspiracy
§ 964
Additional penalties
§ 965
Applicability of part E of subchapter I
§ 966
Authority of Secretary of the Treasury
§ 967
Smuggling of controlled substances; investigations; oaths; subpenas; witnesses; evidence; production of records; territorial limits; fees and mileage of witnesses
§ 968
Service of subpena; proof of service
§ 969
Contempt proceedings
§ 970
Criminal forfeitures
§ 971
Notification, suspension of shipment, and penalties with respect to importation and exportation of listed chemicals
Chapter 15
EGG PRODUCTS INSPECTION
§ 1031
Congressional statement of findings
§ 1032
Congressional declaration of policy
§ 1033
Definitions
§ 1034
Inspection of egg products
§ 1035
Sanitary operating practices in official plants
§ 1036
Pasteurization and labeling of egg products at official plants
§ 1037
Prohibited acts
§ 1038
Cooperation with appropriate State and other governmental agencies; utilization of employees; reimbursement
§ 1039
Eggs and egg products not intended for use as human food; inspection; denaturing or otherwise identifying
§ 1040
Recordkeeping requirements; persons required to maintain records; scope of disclosure; access to records
§ 1041
Enforcement provisions
§ 1042
Reporting of violation to United States attorney for institution of criminal proceedings; procedure; presentation of views
§ 1043
Rules and regulations; administration and enforcement
§ 1044
Exemption of certain activities
§ 1045
Limitation on entry of eggs and egg products and other materials into official plants
§ 1046
Imports
§ 1047
Refusal or withdrawal of inspection services; hearing; grounds; person deemed to have responsible connection with business; finality of order of Secretary; judicial review; other provisions for refusal of services unaffected
§ 1048
Administrative detention of violative articles; duration; release; removal of official marks
§ 1049
Seizure and condemnation proceedings
§ 1050
Jurisdiction of district courts; United States as plaintiff in enforcement and restraining proceedings; subpenas for witnesses
§ 1051
Other Federal laws applicable for administration and enforcement of chapter; prosecution of inquiries; exercise of jurisdiction
§ 1052
State or local regulation
§ 1053
Inspection and administration costs
§ 1054
Annual report to Congressional committees
§ 1055
Authorization of appropriations
§ 1056
Separability
Chapter 16
DRUG ABUSE PREVENTION, TREATMENT, AND REHABILITATION
§ 1101
Congressional findings
§ 1102
Congressional declaration of national policy
§ 1103
Repealed. Pub. L. 100–690, title I, §1007(c)(1), Nov. 18, 1988, 102 Stat. 4187
§ 1104
Repealed. Pub. L. 94–237, §4(c)(1), Mar. 19, 1976, 90 Stat. 244
§ 1115
Notice relating to the control of dangerous drugs
§ 1116
Repealed. Pub. L. 100–690, title I, §1007(c)(1), Nov. 18, 1988, 102 Stat. 4187
§ 1117
Repealed. Pub. L. 98–24, §4(b), Apr. 26, 1983, 97 Stat. 183
§ 1171
Drug abuse prevention function appropriations
§ 1172
Repealed. Pub. L. 98–24, §2(c)(2), Apr. 26, 1983, 97 Stat. 182
§ 1173
Transferred and Omitted
§ 1176
Repealed. Pub. L. 97–35, title IX, §969(a), Aug. 13, 1981, 95 Stat. 595
§ 1177
Special project grants and contracts
§ 1178
Records and audit
§ 1179
National Drug Abuse Training Center
§ 1180
Transferred
§ 1181
Contract authority
§ 1194
Repealed. Pub. L. 98–24, §2(c)(2), Apr. 26, 1983, 97 Stat. 182
Chapter 19
PESTICIDE MONITORING IMPROVEMENTS
§ 1401
Pesticide monitoring and enforcement information
§ 1402
Foreign pesticide information
§ 1403
Pesticide analytical methods
Chapter 20
NATIONAL DRUG CONTROL PROGRAM
§ 1502a
Transferred
§ 1505a
Annual report on development and deployment of narcotics detection technologies
§ 1509
Repealed. Pub. L. 109–469, title XI, §1101(b), Dec. 29, 2006, 120 Stat. 3539
§ 1521
Findings
§ 1522
Purposes
§ 1523
Definitions
§ 1524
Authorization of appropriations
§ 1531
Establishment of drug-free communities support program
§ 1532
Program authorization
§ 1533
Information collection and dissemination with respect to grant recipients
§ 1534
Technical assistance and training
§ 1535
Supplemental grants for coalition mentoring activities
§ 1536
Community-based coalition enhancement grants to address local drug crises
Chapter 21
BIOMATERIALS ACCESS ASSURANCE
§ 1601
Findings
§ 1602
Definitions
§ 1603
General requirements; applicability; preemption
§ 1604
Liability of biomaterials suppliers
§ 1605
Procedures for dismissal of civil actions against biomaterials suppliers
§ 1606
Subsequent impleader of dismissed biomaterials supplier
Chapter 22
NATIONAL DRUG CONTROL POLICY
§ 1701
Definitions
§ 1702
Office of National Drug Control Policy
§ 1703
Appointment and duties of Director and Deputy Directors
§ 1704
Coordination with National Drug Control Program agencies in demand reduction, supply reduction, and State and local affairs
§ 1705
Development, submission, implementation, and assessment of National Drug Control Strategy
§ 1706
High Intensity Drug Trafficking Areas Program
§ 1707
Repealed. Pub. L. 115–271, title VIII, §8222(3), Oct. 24, 2018, 132 Stat. 4143
§ 1708
Emerging Threats Committee, plan, and media campaign
§ 1708a
Repealed. Pub. L. 116–74, §2(b)(1), Nov. 27, 2019, 133 Stat. 1157
§ 1709
Repealed. Pub. L. 109–469, title XI, §1101(a), Dec. 29, 2006, 120 Stat. 3539
§ 1710
Drug Interdiction Coordinator and Committee
§ 1710a
Requirement for disclosure of Federal sponsorship of all Federal advertising or other communication materials
§ 1711
Authorization of appropriations
§ 1712
Repealed. Pub. L. 115–271, title VIII, §8202(b)(2), Oct. 24, 2018, 132 Stat. 4110
§ 1713
Authorization of use of environmentally-approved herbicides to eliminate illicit narcotics crops
§ 1714
Awards for demonstration programs by local partnerships to coerce abstinence in chronic hard-drug users under community supervision through the use of drug testing and sanctions
§ 1715
GAO audit
Chapter 24
INTERNATIONAL NARCOTICS TRAFFICKING
§ 1901
Findings and policy
§ 1902
Purpose
§ 1903
Public identification of significant foreign narcotics traffickers and required reports
§ 1904
Blocking assets and prohibiting transactions
§ 1905
Authorities
§ 1906
Enforcement
§ 1907
Definitions
§ 1908
Judicial Review Commission on Foreign Asset Control
Chapter 25
MISCELLANEOUS ANTI-DRUG ABUSE PROVISIONS
§ 2001
Designation of United States Anti-Doping Agency
§ 2002
Records, audit, and report
§ 2003
Authorization of appropriations
§ 2004
Information sharing
§ 2011
Definitions
§ 2012
Establishment of clearinghouse and advisory council
§ 2013
NMIC requirements and review
§ 2014
Authorization of appropriations
Chapter 26
FOOD SAFETY
§ 2101
Findings
§ 2102
Ensuring the safety of pet food
§ 2103
Ensuring efficient and effective communications during a recall
§ 2104
State and Federal cooperation
§ 2105
Enhanced aquaculture and seafood inspection
§ 2106
Consultation regarding genetically engineered seafood products
§ 2107
Sense of Congress
§ 2108
Annual report to Congress
§ 2109
Publication of annual reports
§ 2110
Rule of construction
Chapter 27
FOOD SAFETY MODERNIZATION
§ 2201
Performance standards
§ 2202
National Agriculture and Food Defense Strategy
§ 2203
Food and Agriculture Coordinating Councils
§ 2204
Building domestic capacity
§ 2205
Food allergy and anaphylaxis management
§ 2206
Alcohol-related facilities
§ 2221
Food emergency response network
§ 2222
Integrated consortium of laboratory networks
§ 2223
Enhancing tracking and tracing of food and recordkeeping
§ 2224
Surveillance
§ 2225
Decontamination and disposal standards and plans
§ 2241
Inspection by the Secretary of Commerce
§ 2242
Foreign offices of the Food and Drug Administration
§ 2243
Smuggled food
§ 2251
Jurisdiction; authorities
§ 2252
Compliance with international agreements
Chapter 28
SANCTIONS WITH RESPECT TO FOREIGN TRAFFICKERS OF ILLICIT SYNTHETIC OPIOIDS
§ 2301
Sense of Congress
§ 2302
Definitions
§ 2311
Identification of foreign opioid traffickers
§ 2312
Imposition of sanctions
§ 2313
Description of sanctions
§ 2313a
Designation of transactions of sanctioned persons as of primary money laundering concern
§ 2314
Waivers
§ 2315
Procedures for judicial review of classified information
§ 2316
Briefings on implementation
§ 2331
Director of National Intelligence program on use of intelligence resources in efforts to sanction foreign opioid traffickers
§ 2332
Authorization of appropriations
§ 2333
Regulatory authority
§ 2334
Termination
§ 2335
Exception relating to importation of goods
Chapter 28A
FENTANYL ERADICATION AND NARCOTICS DETERRENCE OFF FENTANYL
§ 2341
Definitions
§ 2351
Finding; policy
§ 2352
Use of national emergency authorities; reporting
§ 2353
Imposition of sanctions with respect to fentanyl trafficking by transnational criminal organizations
§ 2354
Penalties; waivers; exceptions
§ 2355
Treatment of forfeited property of transnational criminal organizations
§ 2361
Treatment of transnational criminal organizations in suspicious transactions reports of the Financial Crimes Enforcement Network
§ 2371
Exception relating to importation of goods
Chapter 29
INTERNATIONAL SPORTS DOPING
§ 2401
Definitions
§ 2402
Major international doping fraud conspiracies
§ 2403
Criminal penalties and statute of limitations
§ 2404
Coordination and sharing of information with USADA